Tomoko Ito

Dr. Tomoko Ito

Japan Anti-tuberculosis Association, Shin-Yamanote Hospital

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2019 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
TITomoko Ito
Tomoko Ito
NONaoki Otani
Naoki Otani
KFKazuya Fujii
Kazuya Fujii
KMKentaro Mori
Kentaro Mori
MEMasazumi Eriguchi
Masazumi Eriguchi
YKYoshiyuki Koyama
Yoshiyuki Koyama

4 January 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TITomoko Ito
Tomoko Ito
KSKikuya Sugiura
Kikuya Sugiura
AHAya Hasegawa
Aya Hasegawa
WOWakana Ouchi
Wakana Ouchi
Takayuki YoshimotoTakayuki Yoshimoto
Takayuki Yoshimoto
YKYoshiyuki Koyama
Yoshiyuki Koyama
Tumor-derived extracellular vesicles (EVs), as tumor vaccines, carry tumor-associated antigens (TAAs), and were expected to transfer TAAs to antigen-presenting cells. However, treatment with tumor-derived EVs exhibited no obvious antitumor effect on the established tumors, likely due to their immuno-suppressive functions, and also to the poor immunogenicity of TAAs. In order to improve the immune stimulating properties, EVs expressing a highly immunogenic bacterial antigen, 6 kDa early secretory antigenic target (ESAT-6), from Mycobacterium tuberculosis were prepared by genetically modifying the parent tumor cells with a plasmid coding for ESAT-6. Cultured B16 tumor cells were transfected with a ternary complex system consisting of pDNA, polyethylenimine (PEI), and chondroitin sulfate. The cells that were transfected with the ternary complex secreted EVs with a higher number of ESAT-6 epitopes than those transfected by a conventional DNA/PEI binary complex, due to the low cytotoxicity, and durable high expression efficiency of the ternary complex systems. The EVs presenting the ESAT-6 epitope (ESAT-EV) were collected and explored as immune modulatory agents. Dendritic cells (DCs) were differentiated from mouse bone marrow cells and incubated with ESAT-EV. After incubating with the EVs for one day, the DCs expressed a significantly higher level of DC maturation marker, CD86. The DCs treated with ESAT-EV showed a significantly improved antitumor activity in tumor-bearing mice.

1 January 2014 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
TITomoko Ito
Tomoko Ito
YKYoshiyuki Koyama
Yoshiyuki Koyama
MOMakoto Otsuka
Makoto Otsuka

1 June 2015 in MRS Communications
Verified
Journal Article
Closed access
PDF file
TITomoko Ito
Tomoko Ito
MEMasazumi Eriguchi
Masazumi Eriguchi
YKYoshiyuki Koyama
Yoshiyuki Koyama

1 January 2013 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
TITomoko Ito
Tomoko Ito
MOMakoto Otsuka
Makoto Otsuka
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

31 December 2006 in Molecular Therapy
Verified
Journal Article
Open access
TITomoko Ito
Tomoko Ito
KAKeiko Abe
Keiko Abe
CYChieko Yoshihara
Chieko Yoshihara
NTNaoko Iida Tanaka
Naoko Iida Tanaka
YKYoshiyuki Koyama
Yoshiyuki Koyama
Mt is a cross-disciplinary biomedical journal devoted to publishing the most exciting advances in pharmacology and therapeutics, as they pertain to advances in translational and clinical medicine. It is recognized as one of the most prestigious journals in the field. With an impact factor of 6.825*, mt ranks in the top 4.2% of scientific journals in the latest Science Citation Index. Published monthly online and in print.